Constellation Pharmaceuticals (CNST) Stock Analysis

What Constellation Pharmaceuticals does

Constellation Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical entity, dedicated to identifying and advancing novel therapeutic solutions. Its core mission is to address critical unmet medical requirements for patients battling cancers characterized by aberrant gene expression or drug resistance. The company's pipeline features several key candidates: CPI-0610 is undergoing Phase II clinical assessment for myelofibrosis, administered in combination with ruxolitinib. Another significant compound, CPI-1205, is currently in Phase Ib/II clinical trials, targeting metastatic castration-resistant prostate cancer when used alongside androgen receptor signaling inhibitors. Beyond these, Constellation is also progressing CPI-0209 through the Phase I dose-escalation segment of its Phase I/II clinical trial for solid tumors. Established in 2008, the firm was formerly known as Epigenetix, Inc. before rebranding in March of that year to its present name. Constellation Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.

Key metrics

ETFs linked to CNST

Broad-market and Healthcare sector ETFs an investor holding Constellation Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how CNST fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Constellation Pharmaceuticals?

Constellation Pharmaceuticals trades under the ticker CNST on NASDAQ.

Which exchange is CNST listed on?

CNST is listed on NASDAQ.

What sector does Constellation Pharmaceuticals operate in?

Constellation Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CNST in a portfolio?

PortView shows CNST's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.